SARS-CoV-2 Epitopes following Infection and Vaccination Overlap Known Neutralizing Antibody Sites Article

Full Text via DOI: 10.34133/2022/9769803 Web of Science: 000825136200001

Cited authors

  • Yang L, Liang T, Pierson LM, Wang HY, Fletcher JK, Wang S, Bao DR, Zhang LL, Huang Z, Zheng WS, Zhang XM, Park H, Li YW, Robinson JE, Feehan AK, Lyon CJ, Cao J, Morici LA, Li CZ, Roy CJ, Yu XB, Hu T

Abstract

  • Identification of epitopes targeted following virus infection or vaccination can guide vaccine design and development of therapeutic interventions targeting functional sites, but can be laborious. Herein, we employed peptide microarrays to map linear peptide epitopes (LPEs) recognized following SARS-CoV-2 infection and vaccination. LPEs detected by nonhuman primate (NHP) and patient IgMs after SARS-CoV-2 infection extensively overlapped, localized to functionally important virus regions, and aligned with reported neutralizing antibody binding sites. Similar LPE overlap occurred after infection and vaccination, with LPE clusters specific to each stimulus, where strong and conserved LPEs mapping to sites known or likely to inhibit spike protein function. Vaccine-specific LPEs tended to map to sites known or likely to be affected by structural changes induced by the proline substitutions in the mRNA vaccine???s S protein. Mapping LPEs to regions of known functional importance in this manner may accelerate vaccine evaluation and discovery of targets for site-specific therapeutic interventions.

Publication date

  • 2022

International Standard Serial Number (ISSN)

  • 2096-5168

Number of pages

  • 14

Volume

  • 2022